Brief: Crinetics Pharmaceuticals Q1 Net Income USD -66.93 Million
09/05/2024 21:05
May 09 (Reuters) - Crinetics Pharmaceuticals Q1 operating expenses USD 74.169 million. * Q1 basic EPS USD -0.93 * Q1 operating income USD -73.529 million
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million